BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11741233)

  • 1. Stereoselective pharmacokinetics of ifosfamide in male and female rats.
    Wang JJ; Lu H; Chan KK
    AAPS PharmSci; 2000; 2(2):E17. PubMed ID: 11741233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiomer-enantiomer interaction of ifosfamide in the rat.
    Lu H; Wang JJ; Chan KK
    Xenobiotica; 2006 Jun; 36(6):535-49. PubMed ID: 16865821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of phenobarbital on stereoselective metabolism of ifosfamide in rats.
    Lu H; Wang JJ; Chan KK; Young D
    Drug Metab Dispos; 1998 May; 26(5):476-82. PubMed ID: 9571229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselectivity in metabolism of ifosfamide by CYP3A4 and CYP2B6.
    Lu H; Wang JJ; Chan KK; Philip PA
    Xenobiotica; 2006 May; 36(5):367-85. PubMed ID: 16854777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of ifosfamide, 4-hydroxyifosfamide, N2-dechloroethylifosfamide, N3-dechloroethylifosfamide and iphosphoramide mustard in plasma by gas chromatography-mass spectrometry.
    Wang JJ; Chan KK
    J Chromatogr B Biomed Appl; 1995 Dec; 674(2):205-17. PubMed ID: 8788150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective metabolism of ifosfamide by human P-450s 3A4 and 2B6. Favorable metabolic properties of R-enantiomer.
    Roy P; Tretyakov O; Wright J; Waxman DJ
    Drug Metab Dispos; 1999 Nov; 27(11):1309-18. PubMed ID: 10534317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective pharmacokinetics of ifosfamide and its 2- and 3-N-dechloroethylated metabolites in female cancer patients.
    Granvil CP; Ducharme J; Leyland-Jones B; Trudeau M; Wainer IW
    Cancer Chemother Pharmacol; 1996; 37(5):451-6. PubMed ID: 8599868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential in vitro hepatic and intestinal metabolism of ifosfamide in the rat.
    Lu H; Chan KK
    Xenobiotica; 1998 Aug; 28(8):779-84. PubMed ID: 9741956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivo.
    Brain EG; Yu LJ; Gustafsson K; Drewes P; Waxman DJ
    Br J Cancer; 1998 Jun; 77(11):1768-76. PubMed ID: 9667645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacokinetics and stability of isophosphoramide mustard.
    Zheng JJ; Chan KK; Muggia F
    Cancer Chemother Pharmacol; 1994; 33(5):391-8. PubMed ID: 8306413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms.
    Calinski DM; Zhang H; Ludeman S; Dolan ME; Hollenberg PF
    Drug Metab Dispos; 2015 Jul; 43(7):1084-90. PubMed ID: 25934575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of ifosfamide and metabolites between plasma and erythrocytes.
    Kerbusch T; Herben VM; Jeuken MJ; Ouwerkerk J; Keizer HJ; Beijnen JH
    Biopharm Drug Dispos; 2001 Apr; 22(3):99-108. PubMed ID: 11745912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomers.
    Ducharme MP; Bernstein ML; Granvil CP; Gehrcke B; Wainer IW
    Cancer Chemother Pharmacol; 1997; 40(6):531-3. PubMed ID: 9332469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes.
    Granvil CP; Madan A; Sharkawi M; Parkinson A; Wainer IW
    Drug Metab Dispos; 1999 Apr; 27(4):533-41. PubMed ID: 10101149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated oxazaphosphorines are transported predominantly by erythrocytes.
    Highley MS; Schrijvers D; Van Oosterom AT; Harper PG; Momerency G; Van Cauwenberghe K; Maes RA; De Bruijn EA; Edelstein MB
    Ann Oncol; 1997 Nov; 8(11):1139-44. PubMed ID: 9426334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ifosfamide, 2- and 3-dechloroethylifosfamide in plasma and urine of cancer patients treated with a 10-day continuous infusion of ifosfamide.
    Kaijser GP; Keizer HJ; Beijnen JH; Bult A; Underberg WJ
    Anticancer Res; 1996; 16(5B):3247-57. PubMed ID: 8920799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlinear stereoselective pharmacokinetics of ketoconazole in rat after administration of racemate.
    Hamdy DA; Brocks DR
    Chirality; 2009 Jul; 21(7):704-12. PubMed ID: 18988259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal clearance of ifosfamide.
    Springate J; Zamlauski-Tucker MJ; Lu H; Chan KK
    Drug Metab Dispos; 1997 Sep; 25(9):1081-2. PubMed ID: 9311624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid.
    Spiegelstein O; Yagen B; Levy RH; Finnell RH; Bennett GD; Roeder M; Schurig V; Bialer M
    Pharm Res; 1999 Oct; 16(10):1582-8. PubMed ID: 10554101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability of stereoisomeric analogues of ifosfamide.
    Sloderbach A; Hładoń B; Laskowska H
    Acta Physiol Hung; 1996; 84(4):459-60. PubMed ID: 9328631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.